Veeva Systems Inc. trades at $188.66 with a $6.46B net cash position
Veeva Systems Inc.’s share was trading at $188.66 as of June 1st. The company has a structurally advantaged vertical SaaS model, providing the software backbone of the global life sciences industry.
The company’s competitive advantage is anchored in deep domain specialization and regulatory validation requirements. Veeva benefits from compliance-driven workflows, customer captivity, and over 115 live deployments of Vault CRM.
Veeva combines ~75% gross margins, strong free cash flow, and a $6.46B net cash position. The separation from Salesforce strengthened autonomy, enabling full control over product roadmap, margins, and AI integration.
Adoption momentum continues with commitments from 9 of the top 20 global pharmaceutical companies, signaling enterprise penetration.